AAPL351.91-0.87 (-0.25%) ▼|ABBV292.82-1.73 (-0.59%) ▼|ABT104.71-2.74 (-2.55%) ▼|ACN239.28-8.42 (-3.40%) ▼|ADBE235.55-10.45 (-4.25%) ▼|AMAT349.23-1.02 (-0.29%) ▼|AMD503.41-0.87 (-0.17%) ▼|AMGN457.93-4.39 (-0.95%) ▼|AMT183.18-7.56 (-3.96%) ▼|AMZN257.89+0.14 (+0.05%) ▲|AVGO341.60+8.20 (+2.46%) ▲|AXP315.78-3.27 (-1.02%) ▼|BA163.91-1.31 (-0.79%) ▼|BAC49.44-0.64 (-1.28%) ▼|BKNG154.46-3.07 (-1.95%) ▼|BLK1,180.67-17.30 (-1.44%) ▼|BMY61.35-1.58 (-2.51%) ▼|BNY149.79-1.90 (-1.25%) ▼|BRK-B586.76-6.09 (-1.03%) ▼|C119.94-1.38 (-1.14%) ▼|CAT570.79+0.30 (+0.05%) ▲|CL99.61-1.38 (-1.37%) ▼|CMCSA25.31-0.29 (-1.13%) ▼|COF186.78-6.44 (-3.33%) ▼|COP139.48-1.04 (-0.74%) ▼|COST1,110.08-3.66 (-0.33%) ▼|CRM194.52-20.31 (-9.45%) ▼|CSCO95.11+0.59 (+0.62%) ▲|CVS85.81-2.78 (-3.14%) ▼|CVX216.13-1.01 (-0.47%) ▼|DE649.23-4.76 (-0.73%) ▼|DHR225.77-4.14 (-1.80%) ▼|DIS116.94-1.76 (-1.48%) ▼|DUK129.84-0.75 (-0.57%) ▼|EMR159.15-1.50 (-0.93%) ▼|FDX319.94-7.71 (-2.35%) ▼|GD355.63-4.06 (-1.13%) ▼|GE326.40+1.22 (+0.38%) ▲|GEV779.91+16.34 (+2.14%) ▲|GILD170.26+2.68 (+1.60%) ▲|GM84.05+0.38 (+0.45%) ▲|GOOG277.60-3.66 (-1.30%) ▼|GOOGL280.20-3.52 (-1.24%) ▼|GS877.52-14.02 (-1.57%) ▼|HD339.01-8.50 (-2.45%) ▼|HON218.96+1.01 (+0.46%) ▲|IBM231.09-11.42 (-4.71%) ▼|INTC55.17-0.27 (-0.49%) ▼|INTU320.79-24.77 (-7.17%) ▼|ISRG430.53-7.22 (-1.65%) ▼|JNJ278.70-3.85 (-1.36%) ▼|JPM329.96-8.25 (-2.44%) ▼|KO98.79-0.69 (-0.69%) ▼|LIN515.11-8.35 (-1.60%) ▼|LLY1,415.55-16.12 (-1.13%) ▼|LMT590.34+5.13 (+0.88%) ▲|LOW220.46-4.47 (-1.99%) ▼|LRCX210.69-0.14 (-0.07%) ▼|MA645.73-15.98 (-2.42%) ▼|MCD275.82+1.15 (+0.42%) ▲|MDLZ66.75-0.79 (-1.17%) ▼|MDT102.32-0.56 (-0.54%) ▼|META618.87-7.54 (-1.20%) ▼|MMM180.88-0.80 (-0.44%) ▼|MO77.46-1.44 (-1.83%) ▼|MRK143.37-1.09 (-0.75%) ▼|MS183.53-2.04 (-1.10%) ▼|MSFT506.24-11.75 (-2.27%) ▼|MU712.42-6.60 (-0.92%) ▼|NEE84.42-0.92 (-1.08%) ▼|NFLX59.68-1.07 (-1.76%) ▼|NKE35.85-2.41 (-6.30%) ▼|NOW92.90-6.47 (-6.51%) ▼|NVDA155.46-0.68 (-0.44%) ▼|ORCL115.00-4.09 (-3.43%) ▼|PEP142.02-4.41 (-3.01%) ▼|PFE28.47-0.39 (-1.35%) ▼|PG171.72-1.30 (-0.75%) ▼|PLTR156.56-3.83 (-2.39%) ▼|PM194.38-1.66 (-0.85%) ▼|QCOM166.67-1.85 (-1.10%) ▼|RTX198.00+3.11 (+1.60%) ▲|SBUX107.49-1.23 (-1.13%) ▼|SCHW91.84-1.10 (-1.18%) ▼|SO93.60-1.04 (-1.10%) ▼|SPG230.24-2.54 (-1.09%) ▼|T22.29-0.07 (-0.31%) ▼|TMO686.79-4.54 (-0.66%) ▼|TMUS167.90-2.11 (-1.24%) ▼|TSLA380.11+0.37 (+0.10%) ▲|TXN295.86+1.65 (+0.56%) ▲|UBER68.81-1.18 (-1.69%) ▼|UNH389.68-22.34 (-5.42%) ▼|UNP297.03-6.68 (-2.20%) ▼|UPS110.31-1.51 (-1.35%) ▼|USB59.18-1.25 (-2.07%) ▼|V416.77-9.69 (-2.27%) ▼|VZ45.93-0.41 (-0.88%) ▼|WFC82.69-2.15 (-2.53%) ▼|WMT127.52-0.89 (-0.69%) ▼|XOM167.21+0.34 (+0.20%) ▲|AAPL351.91-0.87 (-0.25%) ▼|ABBV292.82-1.73 (-0.59%) ▼|ABT104.71-2.74 (-2.55%) ▼|ACN239.28-8.42 (-3.40%) ▼|ADBE235.55-10.45 (-4.25%) ▼|AMAT349.23-1.02 (-0.29%) ▼|AMD503.41-0.87 (-0.17%) ▼|AMGN457.93-4.39 (-0.95%) ▼|AMT183.18-7.56 (-3.96%) ▼|AMZN257.89+0.14 (+0.05%) ▲|AVGO341.60+8.20 (+2.46%) ▲|AXP315.78-3.27 (-1.02%) ▼|BA163.91-1.31 (-0.79%) ▼|BAC49.44-0.64 (-1.28%) ▼|BKNG154.46-3.07 (-1.95%) ▼|BLK1,180.67-17.30 (-1.44%) ▼|BMY61.35-1.58 (-2.51%) ▼|BNY149.79-1.90 (-1.25%) ▼|BRK-B586.76-6.09 (-1.03%) ▼|C119.94-1.38 (-1.14%) ▼|CAT570.79+0.30 (+0.05%) ▲|CL99.61-1.38 (-1.37%) ▼|CMCSA25.31-0.29 (-1.13%) ▼|COF186.78-6.44 (-3.33%) ▼|COP139.48-1.04 (-0.74%) ▼|COST1,110.08-3.66 (-0.33%) ▼|CRM194.52-20.31 (-9.45%) ▼|CSCO95.11+0.59 (+0.62%) ▲|CVS85.81-2.78 (-3.14%) ▼|CVX216.13-1.01 (-0.47%) ▼|DE649.23-4.76 (-0.73%) ▼|DHR225.77-4.14 (-1.80%) ▼|DIS116.94-1.76 (-1.48%) ▼|DUK129.84-0.75 (-0.57%) ▼|EMR159.15-1.50 (-0.93%) ▼|FDX319.94-7.71 (-2.35%) ▼|GD355.63-4.06 (-1.13%) ▼|GE326.40+1.22 (+0.38%) ▲|GEV779.91+16.34 (+2.14%) ▲|GILD170.26+2.68 (+1.60%) ▲|GM84.05+0.38 (+0.45%) ▲|GOOG277.60-3.66 (-1.30%) ▼|GOOGL280.20-3.52 (-1.24%) ▼|GS877.52-14.02 (-1.57%) ▼|HD339.01-8.50 (-2.45%) ▼|HON218.96+1.01 (+0.46%) ▲|IBM231.09-11.42 (-4.71%) ▼|INTC55.17-0.27 (-0.49%) ▼|INTU320.79-24.77 (-7.17%) ▼|ISRG430.53-7.22 (-1.65%) ▼|JNJ278.70-3.85 (-1.36%) ▼|JPM329.96-8.25 (-2.44%) ▼|KO98.79-0.69 (-0.69%) ▼|LIN515.11-8.35 (-1.60%) ▼|LLY1,415.55-16.12 (-1.13%) ▼|LMT590.34+5.13 (+0.88%) ▲|LOW220.46-4.47 (-1.99%) ▼|LRCX210.69-0.14 (-0.07%) ▼|MA645.73-15.98 (-2.42%) ▼|MCD275.82+1.15 (+0.42%) ▲|MDLZ66.75-0.79 (-1.17%) ▼|MDT102.32-0.56 (-0.54%) ▼|META618.87-7.54 (-1.20%) ▼|MMM180.88-0.80 (-0.44%) ▼|MO77.46-1.44 (-1.83%) ▼|MRK143.37-1.09 (-0.75%) ▼|MS183.53-2.04 (-1.10%) ▼|MSFT506.24-11.75 (-2.27%) ▼|MU712.42-6.60 (-0.92%) ▼|NEE84.42-0.92 (-1.08%) ▼|NFLX59.68-1.07 (-1.76%) ▼|NKE35.85-2.41 (-6.30%) ▼|NOW92.90-6.47 (-6.51%) ▼|NVDA155.46-0.68 (-0.44%) ▼|ORCL115.00-4.09 (-3.43%) ▼|PEP142.02-4.41 (-3.01%) ▼|PFE28.47-0.39 (-1.35%) ▼|PG171.72-1.30 (-0.75%) ▼|PLTR156.56-3.83 (-2.39%) ▼|PM194.38-1.66 (-0.85%) ▼|QCOM166.67-1.85 (-1.10%) ▼|RTX198.00+3.11 (+1.60%) ▲|SBUX107.49-1.23 (-1.13%) ▼|SCHW91.84-1.10 (-1.18%) ▼|SO93.60-1.04 (-1.10%) ▼|SPG230.24-2.54 (-1.09%) ▼|T22.29-0.07 (-0.31%) ▼|TMO686.79-4.54 (-0.66%) ▼|TMUS167.90-2.11 (-1.24%) ▼|TSLA380.11+0.37 (+0.10%) ▲|TXN295.86+1.65 (+0.56%) ▲|UBER68.81-1.18 (-1.69%) ▼|UNH389.68-22.34 (-5.42%) ▼|UNP297.03-6.68 (-2.20%) ▼|UPS110.31-1.51 (-1.35%) ▼|USB59.18-1.25 (-2.07%) ▼|V416.77-9.69 (-2.27%) ▼|VZ45.93-0.41 (-0.88%) ▼|WFC82.69-2.15 (-2.53%) ▼|WMT127.52-0.89 (-0.69%) ▼|XOM167.21+0.34 (+0.20%) ▲|
8.3 C
New York
Wednesday, November 18, 2026

Tag: news

Largest Ever Land Back-Conservation Deal in Calif. Now Complete: Western Rivers Conservancy Conveys Final Acreage to Yurok Tribe in a 47,000-Acre Effort Critical to...

Western Rivers Conservancy and the Yurok Tribe have completed the largest "land back" deal in California history—47,097 acres of ancestral land.

Admissions now open: SPJIMR’s Global Management Programme for future global leaders

From Mumbai to the world—experience education through a dual-campus global management programme MUMBAI, India, June 5, 2025 /PRNewswire/ -- Bharatiya Vidya Bhavan's S.P. Jain Institute of Management...

Hello Group Inc. Announces Unaudited Financial Results for the First Quarter of 2025

BEIJING, June 5, 2025 /PRNewswire/ -- Hello Group Inc. (NASDAQ: MOMO) ("Hello Group" or the "Company"), a leading player in Asia's online social and...

CancerVax Achieves Major Milestone with Successful Creation of Cell Targeting Nanoparticle

Recent independent analyses confirmed that the Company has successfully created a ligand conjugated nanoparticle that can target specific biomarkers on the surface of cancer cells
Recent independent analyses confirmed that the Company has successfully created a ligand conjugated nanoparticle that can target specific biomarkers on the surface of cancer cells

Successful UK market entry programme set to launch for third consecutive year at London Tech Week

West Midlands Growth Company (WMGC) inviting applications from eligible companies for its unique UK market entry programme, with 15 places available for 2025/26.Launch of...

Your Nintendo Switch 2 is going places with JSAUX’s EveryDay Case with Travel Cover

HONG KONG, June 5, 2025 /PRNewswire/ -- Gaming manufacturer JSAUX announces a new accessory for the Nintendo Switch 2, the hybrid console hitting the stores...

NEUBERGER BERMAN RAISES $4 BILLION FOR LATEST GP-LED SECONDARY FUND, MARKING ONE OF THE LARGEST RAISES IN A RAPIDLY GROWING MARKET

NEW YORK, June 5, 2025 /PRNewswire/ -- Neuberger Berman, a private, independent, employee-owned investment manager, is pleased to announce the final close of NB Strategic...

Eco Age relaunches as agency for future fashion

LONDON, June 5, 2025 /PRNewswire/ -- Eco Age, the pioneering sustainability consultancy behind the Green Carpet Fashion Awards, relaunches as a communications agency for future...

Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)

HYDERABAD, INDIA & REYKJAVIK, ICELAND (June 5, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide (“Alvotech”), and Dr. Reddy’s Laboratories Ltd., (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY, along with its subsidiaries hereafter referred to as “Dr. Reddy’s”), today announced that the companies have entered into a collaboration and license agreement to co-develop, manufacture and commercialize a biosimilar candidate to Keytruda® (pembrolizumab) for global markets. Keytruda® (pembrolizumab) is indicated for the treatment of numerous cancer types. In 2024, worldwide sales of Keytruda were US$29.5 billion [1]. The collaboration combines Dr. Reddy’s and Alvotech’s proven capabilities in biosimilars, thereby, speeding up the development process and extending the global reach for this biosimilar candidate.

Wondershare EdrawMax V14.5 Debuts at GITEX Europe: AI-Powered Diagramming Revolutionizes Diagram Creation

BERLIN, June 5, 2025 /PRNewswire/ -- Recently, Wondershare unveiled the latest version of its popular diagramming software, EdrawMax V14.5, at GITEX Europe 2025, one of...

Sino Innovation Lab and MASSPHOTON Collaborate to Enhance Air Quality at China Hong Kong City with Advanced UVC LED Sterilization

HONG KONG, June 5, 2025 /PRNewswire/ -- MASSPHOTON LIMITED, a global leader in gallium nitride (GaN) semiconductor devices and digital disinfection technologies, has successfully...

Hong Leong Asset Management and Hong Leong Bank Launch Hong Leong All Roads Funds in Strategic Partnership with Lombard Odier

KUALA LUMPUR, Malaysia, June 5, 2025 /PRNewswire/ -- Hong Leong Asset Management Bhd ("HLAM"), in collaboration with Hong Leong Bank Berhad ("Hong Leong Bank")...

Sectra’s year-end report 2024/2025: Reporting solid growth in a time of change

LINKÖPING, Sweden, June 5, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) is continuing to deliver results through high customer...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsNews